Synerkine Pharma

Synerkine Pharma

Verified
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain

Launch date
Ownership
Firm valuation
€14—22m (Dealroom.co estimates Dec 2021.)
Naarden North Holland (HQ)

Company information

Edit
Launch date
Ownership
Firm valuation
€14—22m (Dealroom.co estimates Dec 2021.)
  • Edit
DateInvestorsAmountRound
$3.7mSeries A
*
$3.9mSeries A
Total Funding€7m

Recent News about Synerkine Pharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.